An exploratory study of the pharmacokinetics, safety, and erythropoietic effects of roxadustat in healthy cats
{{output}}
Hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitors stimulate endogenous erythropoietin (EPO) production and are used for the treatment of anemia of chronic kidney disease (CKD) in humans. In veterinary medicine, molidustat (MOL) has demonstrated a... ...
